These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6160811)

  • 21. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
    Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
    Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase.
    Smee DF; Knight SS; Duke AE; Robinson WS; Matthews TR; Marion PL
    Antimicrob Agents Chemother; 1985 Feb; 27(2):277-9. PubMed ID: 2580482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of woodchuck hepatitis virus replication by adenine arabinoside monophosphate coupled to lactosaminated poly-L-lysine and administered by intramuscular route.
    Fiume L; Di Stefano G; Busi C; Mattioli A; Rapicetta M; Giuseppetti R; Ciccaglione AR; Argentini C
    Hepatology; 1995 Oct; 22(4 Pt 1):1072-7. PubMed ID: 7557853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acyclovir and vidarabine monophosphate: comparison of iontophoretic and intravenous administration for the treatment of HSV-1 stromal keratitis.
    Hill JM; Kwon BS; Burch KD; Deback J; Whang I; Jones GT; Luke B; Harp R; Shimomura Y; Hull DS; Gangarosa LP
    Am J Med; 1982 Jul; 73(1A):300-4. PubMed ID: 6179415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of vidarabine in the treatment of infants and children with infections due to herpesviruses.
    Shope TC; Kauffman RE; Bowman D; Marcus EL
    J Infect Dis; 1983 Oct; 148(4):721-5. PubMed ID: 6313815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-pressure liquid chromatographic methods for determining arabinosyladenine-5'-monophosphate, arabinosyladenine, and arabinosylhypoxanthine in plasma and urine.
    McCann WP; Hall LM; Siler W; Barton N; Whitley RJ
    Antimicrob Agents Chemother; 1985 Aug; 28(2):265-73. PubMed ID: 2423028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
    Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K
    Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenine arabinoside monophosphate in experimental vaccinia virus infections.
    Werner GT; Metzger E; Sauer O
    Adv Ophthalmol; 1979; 38():72-81. PubMed ID: 93408
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside.
    Lambe CU; Resetar A; Spector T; Koszalka GW; Nelson DJ
    Antimicrob Agents Chemother; 1992 Feb; 36(2):353-60. PubMed ID: 1318679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
    Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
    Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
    Champney KJ; Lauter CB; Bailey EJ; Lerner AM
    J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
    Helland S; Ueland PM
    Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced efficacy of nucleoside analogs and recombinant alpha interferon in weanling mice lethally infected with herpes simplex virus type 2.
    Crane LR; Sunstrum JC
    Antiviral Res; 1988; 9(1-2):1-9. PubMed ID: 2455473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iontophoretic application of adenine arabinoside monophosphate for the treatment of herpes simplex virus type 2 skin infections in hairless mice.
    Kwon BS; Hill JM; Wiggins C; Tuggle C
    J Infect Dis; 1979 Dec; 140(6):1014. PubMed ID: 94335
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of steroids and adenine-arabinoside (araA) on growth and HBsAg production of a human hepatoma cell line.
    Clementi M; Bagnarelli P; Pauri P
    Arch Virol; 1983; 75(1-2):137-41. PubMed ID: 6187317
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures.
    Bryson YJ; Kronenberg LH
    Antimicrob Agents Chemother; 1977 Feb; 11(2):299-306. PubMed ID: 848937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study on the pharmacokinetics in mouse of adenine-9-beta-D-arabinofuranoside 5-monophosphate conjugated with lactosaminated albumin.
    Fiume L; Bassi B; Busi C; Mattioli A; Wieland T
    Experientia; 1985 Oct; 41(10):1326-8. PubMed ID: 2412878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin.
    Fiume L; Cerenzia MR; Bonino F; Busi C; Mattioli A; Brunetto MR; Chiaberge E; Verme G
    Lancet; 1988 Jul; 2(8601):13-5. PubMed ID: 2455204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of vidarabine in the treatment of polyarteritis nodosa.
    Fauvelle F; Léon A; Nicolas P; Tod M; Guillevin L; Petitjean O
    Fundam Clin Pharmacol; 1992; 6(1):11-5. PubMed ID: 1348236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a novel adenosine deaminase inhibitor (co-vidarabine, co-V) upon the antiviral activity in vitro and in vivo of vidarabine (Vira-Atm) for DNA virus replication.
    Sloan BJ; Kielty JK; Miller FA
    Ann N Y Acad Sci; 1977 Mar; 284():60-80. PubMed ID: 212990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.